GENETIC CHEMISTRY Trademark

Trademark Overview

On Friday, December 22, 2023, a trademark application was filed for GENETIC CHEMISTRY with the United States Patent and Trademark Office. The USPTO has given the GENETIC CHEMISTRY trademark a serial number of 98327493. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, October 30, 2024. This trademark is owned by Empress Therapeutics, Inc.. The GENETIC CHEMISTRY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, pharmaceutical preparations for treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; therapeutics in the nature of oral products, injectables, topical products, inhalation products, ophthalmic products, otic products, nasal products, rectal products, vaginal products, implants, infusions, transdermal systems, and oral thin films; therapeutic pharmaceuticals for the treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders

Pharmaceutical research and development; scientific and medical research and development; technical scientific research consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; drug discovery platform
genetic chemistry

General Information

Serial Number98327493
Word MarkGENETIC CHEMISTRY
Filing DateFriday, December 22, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations for treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; therapeutics in the nature of oral products, injectables, topical products, inhalation products, ophthalmic products, otic products, nasal products, rectal products, vaginal products, implants, infusions, transdermal systems, and oral thin films; therapeutic pharmaceuticals for the treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
Goods and ServicesPharmaceutical research and development; scientific and medical research and development; technical scientific research consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; drug discovery platform

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, December 22, 2023NEW APPLICATION ENTERED
Thursday, April 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, July 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, July 28, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 24, 2024ASSIGNED TO EXAMINER
Sunday, July 28, 2024NON-FINAL ACTION WRITTEN
Monday, October 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2024FINAL REFUSAL WRITTEN
Wednesday, October 30, 2024FINAL REFUSAL E-MAILED
Wednesday, October 30, 2024NOTIFICATION OF FINAL REFUSAL EMAILED

Related Keywords

chemistry genetic disorders diseases products development research pharmaceuticals microbial biotechnology field oral